top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

BioAesthetics Appoints Dr. Juliana Blum as CEO to Drive Advancement of Innovative Graft Technology

1 min read

Durham, NC, August 26, 2024 (Business Wire) -- Dr. Juliana Blum has been appointed CEO of BioAesthetics, to lead the advancement of its innovative graft technology. This leadership change is aimed at enhancing product development and commercialization, with Dr. Blum’s background as a co-founder of Humacyte expected to be instrumental. The transition underscores BioAesthetics’ commitment to progressing its technology toward clinical application.

Read full article here.

Recent Posts

Tune Therapeutics Secures $175M to Advance Epigenetic Silencing Platform into Clinical Trials

Durham, NC and Seattle, WA, January 12, 2025 (Business Wire) -- Tune Therapeutics has raised $175 million in Series B funding to...

Ribometrix Names William S. Marshall, Ph.D., as CEO to Drive Breakthrough RNA-Targeting Therapeutics

Durham, NC, January 09, 2025 (Globe newswire) -- Ribometrix has appointed Dr. William S. Marshall as CEO and Dr. Katie Warner as CSO,...

Kardigan Debuts with $300M and Visionary Team to Revolutionize Cardiovascular Medicine Through Personalized Therapies

San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure...

Comments

Life Science Headlines

Tune Therapeutics Secures $175M to Advance Epigenetic Silencing Platform into Clinical Trials

Ribometrix Names William S. Marshall, Ph.D., as CEO to Drive Breakthrough RNA-Targeting Therapeutics

Kardigan Debuts with $300M and Visionary Team to Revolutionize Cardiovascular Medicine Through Personalized Therapies

City Therapeutics Appoints Andrew Orth as CEO to Propel RNAi Innovation into Clinical Development

Stryker to Acquire Inari Medical in $4.9B Deal, Expanding Leadership in Peripheral Vascular Care

Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants

VectorY Therapeutics Appoints Jim Scibetta as CEO and Expands U.S. Presence

Akamis Bio Secures $60M in Series A Prime Funding to Advance Oncology Pipeline

Borealis Biosciences Appoints Christian Hordo as CEO and Secures $30M in Series A Extension

AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B

bottom of page